Upadacitinib

Upadacitinib
Trade Name
Orphan Indication Still’s disease
USA Market Approval USA
USA Designation Date 2015-09-18 00:00:00
Sponsor AbbVie, Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064